NCT00927537已完成不适用
Data Collection on Hypertension and Its Treatment With Kinzal®/ Kinzalplus®
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Bayer
- 入组人数
- 2,052
- 主要终点
- Blood pressure
研究概览
简要总结
The efficacy and tolerability of an antihypertensive treatment with Telmisartan is followed over 3-4 months
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Hypertensive patients seen by the physician requiring antihypertensive treatment
排除标准
- •According to the local drug information
研究组 & 干预措施
Group 1
干预措施: Telmisartan (Kinzal/Pritor, BAY68-9291) (Drug)
Group 2
干预措施: Telmisartan (Kinzal/Pritor, BAY68-9291) + Hydrochlorothiazide (Drug)
结局指标
主要结局
Blood pressure
时间窗: After 1-2 weeks, 1month, 3-4 months
次要结局
- Change in Mean heart rate (bpm)(Baseline and 3-4 month)
- Change in Mean Weight (kg)(Baseline and 3-4 month)
- Change in Mean laboratory parameters (total cholesterol, LDL, HDL, triglyceride, fasting blood glucose)(Baseline and 3-4 month)
- Patient Medical History: Duration of hypertension, Pre-treatment of hypertension, Comorbidities and Concomitant treatment(Baseline)
- Final evaluation of efficacy (very good, good, sufficient, insufficient) and tolerability (very good, good, sufficient, insufficient) of treatment by the physician.(After 3-4 month)
研究者
相似试验
已完成
不适用
Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and PatientsHypertensionNCT02242851Boehringer Ingelheim5,018
已完成
不适用
Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk HypertensivesObesityHypertensionNCT00539487Boehringer Ingelheim5,827
已完成
不适用
Telmisartan Tab HypertensionHypertensionNCT00890084Boehringer Ingelheim2,913
已完成
不适用
Fimasartan Blood Pressure Lowering After Acute StrokeIschemic StrokeHypertensionTransient Ischemic AttackNCT03231293Boryung Pharmaceutical Co., Ltd1,035
已完成
不适用
Efficacy of Telmisaltan in Hypertension Patients after Pulmonary Resectionsung CancerJPRN-UMIN000001851Toneyama National Hospital20